JP6496322B2 - 酵素の切断活性の検出 - Google Patents

酵素の切断活性の検出 Download PDF

Info

Publication number
JP6496322B2
JP6496322B2 JP2016549647A JP2016549647A JP6496322B2 JP 6496322 B2 JP6496322 B2 JP 6496322B2 JP 2016549647 A JP2016549647 A JP 2016549647A JP 2016549647 A JP2016549647 A JP 2016549647A JP 6496322 B2 JP6496322 B2 JP 6496322B2
Authority
JP
Japan
Prior art keywords
cleavage
molecule
site
binding
capture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016549647A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016535282A (ja
JP2016535282A5 (https=
Inventor
ポール・デイビス
ギータ・パレク
ジェイムズ・ショウテン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mologic Ltd
Original Assignee
Mologic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mologic Ltd filed Critical Mologic Ltd
Publication of JP2016535282A publication Critical patent/JP2016535282A/ja
Publication of JP2016535282A5 publication Critical patent/JP2016535282A5/ja
Application granted granted Critical
Publication of JP6496322B2 publication Critical patent/JP6496322B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • G01N2800/122Chronic or obstructive airway disorders, e.g. asthma COPD
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/38Pediatrics
    • G01N2800/382Cystic fibrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2016549647A 2013-10-23 2014-10-23 酵素の切断活性の検出 Active JP6496322B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1318728.1 2013-10-23
GB201318728A GB201318728D0 (en) 2013-10-23 2013-10-23 Detection of cleavage activity of an enzyme
PCT/GB2014/053171 WO2015059487A2 (en) 2013-10-23 2014-10-23 Detection of cleavage activity of an enzyme

Publications (3)

Publication Number Publication Date
JP2016535282A JP2016535282A (ja) 2016-11-10
JP2016535282A5 JP2016535282A5 (https=) 2017-11-30
JP6496322B2 true JP6496322B2 (ja) 2019-04-03

Family

ID=49727217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016549647A Active JP6496322B2 (ja) 2013-10-23 2014-10-23 酵素の切断活性の検出

Country Status (11)

Country Link
US (2) US10866236B2 (https=)
EP (1) EP3060915B1 (https=)
JP (1) JP6496322B2 (https=)
CN (1) CN105940304B (https=)
AU (1) AU2014338709B2 (https=)
BR (1) BR112016008956A2 (https=)
CA (1) CA2928308C (https=)
GB (1) GB201318728D0 (https=)
MX (1) MX371379B (https=)
RU (1) RU2016119422A (https=)
WO (1) WO2015059487A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201605110D0 (en) 2016-03-24 2016-05-11 Mologic Ltd Detecting sepsis
EP3440113A1 (en) * 2016-04-08 2019-02-13 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
US20190360019A1 (en) * 2016-11-16 2019-11-28 Universal Biosensors Pty Ltd Cleavage event transduction methods and products
ES2931536T3 (es) * 2017-08-31 2022-12-30 Somaprobes Sl Ensayo de flujo lateral para detectar la presencia de una célula de mamífero o bacterias específicas en una muestra biológica
CN111630162A (zh) * 2017-10-04 2020-09-04 博德研究所 基于crispr效应系统的诊断
US11732009B2 (en) * 2018-06-08 2023-08-22 Glympse Bio, Inc. Activity sensor with tunable analyte
GB201812331D0 (en) * 2018-07-27 2018-09-12 Mologic Ltd Bacterial vaginosis diagnostic
JP2022515728A (ja) * 2018-12-20 2022-02-22 武田薬品工業株式会社 好中球エラスターゼの新規な活性ベースのプローブおよびその使用
JP2023542867A (ja) 2020-09-11 2023-10-12 グリンプス バイオ, インコーポレイテッド 疾患の検出/診断、病期分類、モニタリング及び処置のための生体外でのプロテアーゼ活性検出

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795702A (en) 1986-02-05 1989-01-03 Immunogon Associates Diagnostic method for gonorrhea by assay of IgA1 fragments
WO2003102544A2 (en) 2002-05-31 2003-12-11 Cognosci, Inc. Assays for measuring matrix metalloproteinase activities
EP1452868A2 (en) * 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
WO2004099784A2 (en) 2003-05-06 2004-11-18 Anamar Medical Ab Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
GB0311961D0 (en) * 2003-05-23 2003-06-25 Health Prot Agency Mass-based toxin assay and substrates therefor
US20050079566A1 (en) * 2003-09-10 2005-04-14 Caterer Nigel Robert Analytical methods for determination of proteolytic cleavage at specific sites
ATE488766T1 (de) * 2004-06-21 2010-12-15 Progenra Inc Diagnostik und screening-methode und kit in verbindung mit proteolytischer aktivität
EP1889919A4 (en) 2005-05-20 2009-04-15 Mitsubishi Kagaku Iatron Inc PROCESS FOR ENZYMANALYSIS
GB2435511A (en) * 2006-02-23 2007-08-29 Mologic Ltd Protease detection
GB2437311A (en) 2006-04-07 2007-10-24 Mologic Ltd A protease detection product
US7897360B2 (en) * 2006-12-15 2011-03-01 Kimberly-Clark Worldwide, Inc. Enzyme detection techniques
WO2012154272A1 (en) * 2011-02-25 2012-11-15 Wellstat Diagnostics, Llc Assays for detecting enzymatic activity
WO2013116791A1 (en) 2012-02-02 2013-08-08 Mosaic Biosciences, Inc. Biomaterials for delivery of blood extracts and methods of using same
GB201206976D0 (en) 2012-04-20 2012-06-06 Mologic Ltd An enzyme detection device

Also Published As

Publication number Publication date
CA2928308C (en) 2023-07-11
RU2016119422A (ru) 2017-11-28
MX2016005313A (es) 2017-03-01
JP2016535282A (ja) 2016-11-10
GB201318728D0 (en) 2013-12-04
US20200378963A1 (en) 2020-12-03
US10866236B2 (en) 2020-12-15
CN105940304A (zh) 2016-09-14
EP3060915A2 (en) 2016-08-31
AU2014338709A1 (en) 2016-06-02
EP3060915B1 (en) 2018-12-05
CN105940304B (zh) 2019-09-13
US20160238596A1 (en) 2016-08-18
CA2928308A1 (en) 2015-04-30
BR112016008956A2 (pt) 2017-09-19
WO2015059487A3 (en) 2015-09-17
MX371379B (es) 2020-01-28
WO2015059487A2 (en) 2015-04-30
AU2014338709B2 (en) 2020-06-25
US12320804B2 (en) 2025-06-03

Similar Documents

Publication Publication Date Title
US12320804B2 (en) Detection of cleavage activity of an enzyme
US11953506B2 (en) Monitoring inflammation status
EP2839288B1 (en) An enzyme detection device
US10197571B2 (en) Enzyme detection device
US20090111091A1 (en) Specimen pretreatment liquid, kit for measuring virus, and method for detecting virus
US20050186646A1 (en) Rapid assay to detect ADAMTS-13 activity
CN101180405A (zh) 酶分析方法
US20040029200A1 (en) Method and kits for the detection of renal cell carcinoma in a biological fluid of a patient
US20150233921A1 (en) Detection of subject biomarker diagnostic assay for dengue fever and the differentiation of dengue hemorrhagic fever
US20250157661A1 (en) Monitoring inflammation status
US20180246121A1 (en) Immunological test method and immunological test kit
US20160257988A1 (en) Indicator Molecules For Use In Detecting Enzyme Cleavage Activity
JP2003527607A (ja) 乳癌の検出および診断のための新規バイオマーカーとしてのリソソームペプスタチン非感受性タンパク質分解酵素

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171023

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171023

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180524

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180612

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180911

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190308

R150 Certificate of patent or registration of utility model

Ref document number: 6496322

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250